Fortitude pays ~$1M for 9.4% of HeartSciences at 22% premium

Fortitude paid approximately $1 million for a 9.4% stake in HeartSciences at a 22% premium before shareholders vote on the proposed merger. The vote date has not been set, and failure to approve the deal could leave HeartSciences facing liquidation.